PECAM1 and myeloid sarcoma: Coexpression of CR1 and CR2 was observed on the surface of CD31+CD25− naive CD4+ T cells from healthy controls (Figure 4B) and MS patients reconstituting their T cells after alemtuzumab treatment (Supplemental Figure 4A).